Literature DB >> 8349810

A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C.

J A Mollick1, G G Miller, J M Musser, R G Cook, D Grossman, R R Rich.   

Abstract

Streptococcus pyogenes (group A Streptococcus) has re-emerged in recent years as a cause of severe human disease. Because extracellular products are involved in streptococcal pathogenesis, we explored the possibility that a disease isolate expresses an uncharacterized superantigen. We screened culture supernatants for superantigen activity with a major histocompatibility complex class II-dependent T cell proliferation assay. Initial fractionation with red dye A chromatography indicated production of a class II-dependent T cell mitogen by a toxic shock-like syndrome (TSLS) strain. The amino terminus of the purified streptococcal superantigen was more homologous to the amino termini of staphylococcal enterotoxins B, C1, and C3 (SEB, SEC1, and SEC3), than to those of pyrogenic exotoxins A, B, C or other streptococcal toxins. The molecule, designated SSA, had the same pattern of class II isotype usage as SEB in T cell proliferation assays. However, it differed in its pattern of human T cell activation, as measured by quantitative polymerase chain reaction with V beta-specific primers. SSA activated human T cells that express V beta 1, 3, 15 with a minor increase of V beta 5.2-bearing cells, whereas SEB activated V beta 3, 12, 15, and 17-bearing T cells. Immunoblot analysis of 75 disease isolates from several localities detected SSA production only in group A streptococci, and found that SSA is apparently confined to only three clonal lineages as defined by multilocus enzyme electrophoresis typing. Isolates of one of these lineages, (electrophoretic type 2) are strongly associated with TSLS. The data identify SSA as a novel streptococcal superantigen that appears to be more related structurally to staphylococcal enterotoxins than to streptococcal exotoxins. Because abundant SSA production is apparently confined to only three streptococcal clonal lineages, the data also suggest that the SSA gene has only recently been acquired by S. pyogenes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349810      PMCID: PMC294905          DOI: 10.1172/JCI116641

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  Class II MHC molecules are specific receptors for staphylococcus enterotoxin A.

Authors:  J A Mollick; R G Cook; R R Rich
Journal:  Science       Date:  1989-05-19       Impact factor: 47.728

2.  High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR.

Authors:  J D Fraser
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

3.  Localization of an immune functional site on staphylococcal enterotoxin A using the synthetic peptide approach.

Authors:  C H Pontzer; J K Russell; H M Johnson
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

5.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

6.  Nucleotide sequence of the type A streptococcal exotoxin (erythrogenic toxin) gene from Streptococcus pyogenes bacteriophage T12.

Authors:  C R Weeks; J J Ferretti
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

7.  Nucleotide sequence of the enterotoxin B gene from Staphylococcus aureus.

Authors:  C L Jones; S A Khan
Journal:  J Bacteriol       Date:  1986-04       Impact factor: 3.490

8.  V beta-specific stimulation of human T cells by staphylococcal toxins.

Authors:  J Kappler; B Kotzin; L Herron; E W Gelfand; R D Bigler; A Boylston; S Carrel; D N Posnett; Y Choi; P Marrack
Journal:  Science       Date:  1989-05-19       Impact factor: 47.728

9.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

Authors:  D L Stevens; M H Tanner; J Winship; R Swarts; K M Ries; P M Schlievert; E Kaplan
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

10.  Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes.

Authors:  K Nelson; P M Schlievert; R K Selander; J M Musser
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  41 in total

1.  Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals.

Authors:  P M Schlievert; L M Jablonski; M Roggiani; I Sadler; S Callantine; D T Mitchell; D H Ohlendorf; G A Bohach
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

2.  Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A.

Authors:  H Müller-Alouf; T Proft; T M Zollner; D Gerlach; E Champagne; P Desreumaux; C Fitting; C Geoffroy-Fauvet; J E Alouf; J M Cavaillon
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

3.  Immune cell subsets in necrotizing fasciitis: an immunohistochemical analysis.

Authors:  A J Saenz; A F Koreishi; A E Rosenberg; R L Kradin
Journal:  Virchows Arch       Date:  2009-06-16       Impact factor: 4.064

Review 4.  Group A streptococcus--from basic science to clinical disease.

Authors:  D L Stevens
Journal:  West J Med       Date:  1996-01

5.  Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes.

Authors:  Y Kamezawa; T Nakahara; S Nakano; Y Abe; J Nozaki-Renard; T Isono
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

6.  Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies.

Authors:  Kaushik Dutta; Avanish K Varshney; Matthew C Franklin; Michael Goger; Xiaobo Wang; Bettina C Fries
Journal:  J Biol Chem       Date:  2015-01-08       Impact factor: 5.157

7.  Humoral and cellular immune recognition of Helicobacter pylori proteins are not concordant.

Authors:  S A Sharma; G G Miller; G I Perez-Perez; R S Gupta; M J Blaser
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

8.  Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF.

Authors:  K H Schmidt; D Gerlach; L Wollweber; W Reichardt; K Mann; J H Ozegowski; B Fleischer
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

9.  Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).

Authors:  A Norrby-Teglund; D Newton; M Kotb; S E Holm; M Norgren
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

10.  Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes.

Authors:  K B Reda; V Kapur; J A Mollick; J G Lamphear; J M Musser; R R Rich
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.